Inovio Pharmaceuticals Inc. (INO) Social Stream
Inovio Pharmaceuticals Inc (INO) Price Targets From Analysts
Use the tables below to see what analysts covering Inovio Pharmaceuticals Inc think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-10 | 9 | $35 | $6 | $13.111 | $3.65 | 259.21% |
| 2021-11-12 | 9 | $35 | $6 | $13 | $3.65 | 256.16% |
| 2021-12-14 | 8 | $35 | $6 | $13.875 | $3.65 | 280.14% |
| 2021-12-29 | 8 | $35 | $6 | $13.625 | $3.65 | 273.29% |
| 2022-02-09 | 7 | $35 | $6 | $13.375 | $3.65 | 266.44% |
| 2022-03-04 | 8 | $30 | $3 | $11 | $3.65 | 201.37% |
The Trend in the Analyst Price Target
Over the past 21 months, INO's average price target has gone down $4.5.
Over the past 114 days, INO's average upside potential has been 164.01%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-12 | 8 | 35 | 6 | 13.875 | 7.35 | 88.78% |
| 2021-12-14 | 8 | 35 | 6 | 13.875 | 5.91 | 134.77% |
| 2022-01-21 | 8 | 35 | 6 | 13.375 | 3.92 | 241.2% |
| 2022-03-04 | 8 | 30 | 3 | 11.000 | 3.11 | 253.7% |
| 2022-03-04 | 8 | 30 | 3 | 11.500 | 3.11 | 269.77% |
INO Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.5 | 2 | 0 | 6 | 0 | 0 | 8 |
The Trend in the Broker Recommendations
INO's average broker recommendation rating worsened by 0.5 over the prior 21 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- Inovio Pharmaceuticals Inc's variance in analysts' estimates is lower than -697.48% of all US stocks.
- Inovio Pharmaceuticals Inc's upside potential (average analyst target price relative to current price) is greater than 749.9% of stocks in the mid market cap category.
- Inovio Pharmaceuticals Inc's average analyst price target is greater than 83.42% of stocks in the mid market cap category.
- In terms of how Inovio Pharmaceuticals Inc fares relative to Healthcare stocks, note that its number of analysts covering the stock is higher than 525.41% of that group.
Stocks similar to Inovio Pharmaceuticals Inc in the Medical Equipment industry regarding analyst recommendations and price targets are ICUI, IART, and HAE.
Is INO a Buy, Hold or Sell? See the POWR Ratings now!